{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:46:03Z","timestamp":1791751563967,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21 AG072142"],"award-info":[{"award-number":["R21 AG072142"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R35 NS111619"],"award-info":[{"award-number":["R35 NS111619"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.molpha.2026.100154","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:53:00Z","timestamp":1788187980000},"page":"100154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanism of activity inversion for GluN2B-selective negative allosteric modulators"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2330-2864","authenticated-orcid":false,"given":"Steven A.","family":"Kell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-3978","authenticated-orcid":false,"given":"Scott J.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim A.","family":"Tahirovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara A.","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose M.","family":"Santangelo Freel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C.","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3750-9615","authenticated-orcid":false,"given":"Stephen F.","family":"Traynelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.molpha.2026.100154_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pharmrev.120.000131","article-title":"Structure, function, and pharmacology of glutamate receptor ion channels","volume":"73","author":"Hansen","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/cne.903470112","article-title":"Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats","volume":"347","author":"Akazawa","year":"1994","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.1016\/j.molpha.2026.100154_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.molpha.2026.100154_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biopsych.2023.03.020","article-title":"GluN2D subunit in parvalbumin interneurons regulates prefrontal cortex feedforward inhibitory circuit and molecular networks relevant to schizophrenia","volume":"94","author":"Gawande","year":"2023","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jphs.2016.10.002","article-title":"Human GRIN2B variants in neurodevelopmental disorders","volume":"132","author":"Hu","year":"2016","journal-title":"J Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrn2153","article-title":"NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders","volume":"8","author":"Lau","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.molpha.2026.100154_bib9","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.232892","article-title":"An autism-associated mutation in GluN2B prevents NMDA receptor trafficking and interferes with dendrite growth","volume":"132","author":"Sceniak","year":"2019","journal-title":"J Cell Sci"},{"issue":"11","key":"10.1016\/j.molpha.2026.100154_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2011.52","article-title":"Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia","volume":"1","author":"Tarabeux","year":"2011","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.molpha.2026.100154_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cophys.2017.12.013","article-title":"De novo mutations and rare variants occurring in NMDA receptors","volume":"2","author":"XiangWei","year":"2018","journal-title":"Curr Opin Physiol"},{"issue":"3","key":"10.1016\/j.molpha.2026.100154_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12264-017-0191-5","article-title":"Mutations of N-methyl-D-aspartate receptor subunits in epilepsy","volume":"34","author":"Xu","year":"2018","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.molpha.2026.100154_bib13","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18949.1","article-title":"Distinct roles of GRIN2A and GRIN2B variants in neurological conditions","volume":"8","author":"Myers","year":"2019","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1523\/JNEUROSCI.08-01-00185.1988","article-title":"Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists","volume":"8","author":"Choi","year":"1988","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.molpha.2026.100154_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0165-6147(00)89070-7","article-title":"NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release","volume":"16","author":"Mody","year":"1995","journal-title":"Trends Pharmacol Sci"},{"issue":"19","key":"10.1016\/j.molpha.2026.100154_bib16","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1523\/JNEUROSCI.6371-11.2012","article-title":"Synaptic NMDA receptors mediate hypoxic excitotoxic death","volume":"32","author":"Wroge","year":"2012","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.molpha.2026.100154_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41386-023-01614-3","article-title":"Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry","volume":"49","author":"Hanson","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.molpha.2026.100154_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3171\/jns.1999.91.5.0737","article-title":"Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators","volume":"91","author":"Morris","year":"1999","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.molpha.2026.100154_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1527-3458.1996.tb00301.x","article-title":"CGS 19755 (Selfotel): a novel neuroprotective agent against CNS injury","volume":"2","author":"P\u00e9rez-Pinz\u00f3n","year":"1996","journal-title":"CNS Drug Rev"},{"issue":"13","key":"10.1016\/j.molpha.2026.100154_bib22","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.285.13.1719","article-title":"Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial","volume":"285","author":"Sacco","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0920-1211(93)90031-2","article-title":"The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy","volume":"16","author":"Sveinbjornsdottir","year":"1993","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148129","article-title":"MPX-004 and MPX-007: new pharmacological tools to study the physiology of NMDA receptors containing the GluN2A subunit","volume":"11","author":"Volkmann","year":"2016","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.molpha.2026.100154_bib25","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1021\/jm8002153","article-title":"Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists","volume":"51","author":"Tahirovic","year":"2008","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.molpha.2026.100154_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0026-895X(25)13275-6","article-title":"Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors","volume":"44","author":"Williams","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"16","key":"10.1016\/j.molpha.2026.100154_bib27","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1021\/jm00016a017","article-title":"(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses","volume":"38","author":"Chenard","year":"1995","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.molpha.2026.100154_bib28","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1021\/jm400652r","article-title":"Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C\/GluN2D selective antagonists","volume":"56","author":"Acker","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.molpha.2026.100154_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34711","article-title":"An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups","volume":"7","author":"Perszyk","year":"2018","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.molpha.2026.100154_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuron.2016.01.016","article-title":"Positive allosteric modulators of GluN2A-containing NMDARs with distinct modes of action and impacts on circuit function","volume":"89","author":"Hackos","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2026.100154_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116576","article-title":"Discovery of pyrazolo[1,5-a]pyrazin-4-ones as potent and brain penetrant GluN2A-selective positive allosteric modulators reducing AMPA receptor binding activity","volume":"56","author":"Sakurai","year":"2022","journal-title":"Bioorg Med Chem"},{"issue":"13","key":"10.1016\/j.molpha.2026.100154_bib32","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1021\/acs.jmedchem.2c00313","article-title":"SAGE-718: a first-in-class N-methyl-D-aspartate receptor positive allosteric modulator for the potential treatment of cognitive impairment","volume":"65","author":"Hill","year":"2022","journal-title":"J Med Chem"},{"issue":"14","key":"10.1016\/j.molpha.2026.100154_bib33","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1021\/acs.jmedchem.9b01733","article-title":"Discovery of dihydropyrrolo[1,2-a]pyrazin-3(4H)-one-based second-generation GluN2C- and GluN2D-selective positive allosteric modulators (PAMs) of the N-methyl-D-aspartate (NMDA) receptor","volume":"63","author":"Epplin","year":"2020","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41589-019-0449-5","article-title":"Biased modulators of NMDA receptors control channel opening and ion selectivity","volume":"16","author":"Perszyk","year":"2020","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1021\/acschemneuro.7b00329","article-title":"A novel negative allosteric modulator selective for GluN2C\/2D-containing NMDA receptors inhibits synaptic transmission in hippocampal interneurons","volume":"9","author":"Swanger","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.molpha.2026.100154_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuropharm.2012.04.027","article-title":"TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner","volume":"63","author":"Edman","year":"2012","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.molpha.2026.100154_bib37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1124\/mol.114.094516","article-title":"Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator","volume":"86","author":"Khatri","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"17","key":"10.1016\/j.molpha.2026.100154_bib38","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1021\/acschemneuro.3c00181","article-title":"Development of a dihydroquinoline-pyrazoline GluN2C\/2D-selective negative allosteric modulator of the N-methyl-D-aspartate receptor","volume":"14","author":"D\u2019Erasmo","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.neuron.2015.02.008","article-title":"Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects","volume":"85","author":"Yuan","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41467-019-08291-1","article-title":"Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors","volume":"10","author":"Regan","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(96)00089-7","article-title":"Modulation and block of ion channels: a new biology of polyamines","volume":"9","author":"Williams","year":"1997","journal-title":"Cell Signal"},{"issue":"13","key":"10.1016\/j.molpha.2026.100154_bib42","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1021\/acs.jmedchem.7b00239","article-title":"The structure-activity relationship of a tetrahydroisoquinoline class of N-methyl-D-aspartate receptor modulators that potentiates GluN2B-containing N-methyl-D-aspartate receptors","volume":"60","author":"Strong","year":"2017","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/acschemneuro.0c00561","article-title":"Distinct GluN1 and GluN2 structural determinants for subunit-selective positive allosteric modulation of N-methyl-D-aspartate receptors","volume":"12","author":"Strong","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"44","key":"10.1016\/j.molpha.2026.100154_bib44","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.1523\/JNEUROSCI.2619-13.2013","article-title":"The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors","volume":"33","author":"Paul","year":"2013","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.molpha.2026.100154_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0028-3908(00)00197-0","article-title":"Distinct effect of pregnenolone sulfate on NMDA receptor subtypes","volume":"40","author":"Ceccon","year":"2001","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuroscience.2005.08.058","article-title":"Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate","volume":"137","author":"Horak","year":"2006","journal-title":"Neuroscience"},{"issue":"46","key":"10.1016\/j.molpha.2026.100154_bib47","doi-asserted-by":"crossref","first-page":"10318","DOI":"10.1523\/JNEUROSCI.2099-04.2004","article-title":"Molecular mechanism of pregnenolone sulfate action at NR1\/NR2B receptors","volume":"24","author":"Horak","year":"2004","journal-title":"J Neurosci"},{"issue":"16","key":"10.1016\/j.molpha.2026.100154_bib48","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1021\/acs.jmedchem.9b00591","article-title":"Neuroactive steroid N-methyl-D-aspartate receptor positive allosteric modulators: synthesis, SAR, and pharmacological activity","volume":"62","author":"La","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.molpha.2026.100154_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2014.05.027","article-title":"Different oxysterols have opposing actions at N-methyl-D-aspartate receptors","volume":"85","author":"Linsenbardt","year":"2014","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.molpha.2026.100154_bib50","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.bjp.0704543","article-title":"Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids","volume":"135","author":"Malayev","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00018-022-04667-7","article-title":"Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions","volume":"80","author":"Tang","year":"2023","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.molpha.2026.100154_bib52","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0022-3565(24)35002-5","article-title":"Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-D-aspartate receptors","volume":"290","author":"Masuko","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib53","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ajhg.2016.10.002","article-title":"Mechanistic insight into NMDA receptor dysregulation by rare variants in the GluN2A and GluN2B agonist binding domains","volume":"99","author":"Swanger","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.molpha.2026.100154_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108247","article-title":"Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders","volume":"177","author":"Tang","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady3891","article-title":"GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice","volume":"12","author":"Ge","year":"2026","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/mol.113.085803","article-title":"Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors","volume":"84","author":"Hansen","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib57","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/molpharm.124.001019","article-title":"Mechanisms of action underlying conductance-modifying positive allosteric modulators of the NMDA receptor","volume":"106","author":"Ullman","year":"2024","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2026.100154_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1021\/acschemneuro.2c00779","article-title":"Novel GluN2B-selective NMDA receptor negative allosteric modulator possesses intrinsic analgesic properties and enhances analgesia of morphine in a rodent tail flick pain model","volume":"14","author":"Harris","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2026.100154_bib59","series-title":"NMDA receptor antagonists for neuroprotection","article-title":", inventors; Emory University, NeurOp, Inc, assignee","author":"Liotta","year":"2013"},{"issue":"7247","key":"10.1016\/j.molpha.2026.100154_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nature07993","article-title":"Mechanism of differential control of NMDA receptor activity by NR2 subunits","volume":"459","author":"Gielen","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib61","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.cell.2018.10.043","article-title":"Mechanisms for zinc and proton inhibition of the GluN1\/GluN2A NMDA receptor","volume":"175","author":"Jalali-Yazdi","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib62","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0026-895X(24)23245-4","article-title":"A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine\/isoleucine\/valine binding protein","volume":"55","author":"Masuko","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.molpha.2026.100154_bib63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2009.00304.x","article-title":"Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential","volume":"157","author":"Mony","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"5212","key":"10.1016\/j.molpha.2026.100154_bib64","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.7754371","article-title":"Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines","volume":"268","author":"Traynelis","year":"1995","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1085\/jgp.201511422","article-title":"A conserved structural mechanism of NMDA receptor inhibition: a comparison of ifenprodil and zinc","volume":"146","author":"Sirrieh","year":"2015","journal-title":"J Gen Physiol"},{"issue":"8","key":"10.1016\/j.molpha.2026.100154_bib66","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/3661","article-title":"Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition","volume":"1","author":"Mott","year":"1998","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100154_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)00176-6","article-title":"Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes","volume":"225","author":"Pahk","year":"1997","journal-title":"Neurosci Lett"},{"issue":"17","key":"10.1016\/j.molpha.2026.100154_bib68","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.bmc.2009.05.085","article-title":"Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A\/NR2B N-methyl-D-aspartate receptors","volume":"17","author":"Mosley","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"10.1016\/j.molpha.2026.100154_bib69","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.110.166256","article-title":"Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists","volume":"333","author":"Hansen","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib70","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1124\/mol.112.078568","article-title":"Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators","volume":"82","author":"Burger","year":"2012","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100154_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cell.2020.05.052","article-title":"Structural basis of functional transitions in mammalian NMDA receptors","volume":"182","author":"Chou","year":"2020","journal-title":"Cell"},{"issue":"7605","key":"10.1016\/j.molpha.2026.100154_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature17679","article-title":"Activation of NMDA receptors and the mechanism of inhibition by ifenprodil","volume":"534","author":"Tajima","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molpha.2026.100154_bib73","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J Gen Physiol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib74","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tibs.2015.04.002","article-title":"Emerging structural insights into the function of ionotropic glutamate receptors","volume":"40","author":"Karakas","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.molpha.2026.100154_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.sbi.2018.12.009","article-title":"Dissecting diverse functions of NMDA receptors by structural biology","volume":"54","author":"Wang","year":"2019","journal-title":"Curr Opin Struct Biol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib76","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.neuron.2016.11.006","article-title":"Molecular basis for subtype specificity and high-affinity zinc inhibition in the GluN1-GluN2A NMDA receptor amino-terminal domain","volume":"92","author":"Romero-Hernandez","year":"2016","journal-title":"Neuron"},{"issue":"6187","key":"10.1016\/j.molpha.2026.100154_bib77","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1251915","article-title":"Crystal structure of a heterotetrameric NMDA receptor ion channel","volume":"344","author":"Karakas","year":"2014","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.molpha.2026.100154_bib78","doi-asserted-by":"crossref","first-page":"12812","DOI":"10.1074\/jbc.M115.649723","article-title":"Subtype-dependent N-methyl-D-aspartate receptor amino-terminal domain conformations and modulation by spermine","volume":"290","author":"Sirrieh","year":"2015","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib79","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/mol.63.6.1212","article-title":"Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating","volume":"63","author":"Low","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"6273","key":"10.1016\/j.molpha.2026.100154_bib80","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/345347a0","article-title":"Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons","volume":"345","author":"Traynelis","year":"1990","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.molpha.2026.100154_bib81","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1038\/emboj.2011.203","article-title":"Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines","volume":"30","author":"Mony","year":"2011","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.molpha.2026.100154_bib82","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1021\/acs.jmedchem.4c02912","article-title":"Thienopyrimidinone derivatives as a GluN2B\/C\/D biased, positive allosteric modulator of the N-methyl-D-aspartate receptor","volume":"68","author":"Fritzemeier","year":"2025","journal-title":"J Med Chem"},{"issue":"6748","key":"10.1016\/j.molpha.2026.100154_bib83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/43432","article-title":"Genetic enhancement of learning and memory in mice","volume":"401","author":"Tang","year":"1999","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.molpha.2026.100154_bib84","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/14728222.2014.941286","article-title":"Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline","volume":"18","author":"Wang","year":"2014","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"10.1016\/j.molpha.2026.100154_bib85","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/mol.116.105130","article-title":"GluN2D-containing N-methyl-D-aspartate receptors mediate synaptic transmission in hippocampal interneurons and regulate interneuron activity","volume":"90","author":"Perszyk","year":"2016","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:58:33Z","timestamp":1791748713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0026895X26000544"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100154","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of activity inversion for GluN2B-selective negative allosteric modulators","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100154"}}